Omeros | OMER - Market Capitalization


Omeros reported $583.4M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Cytokinetics USD 8.19B 420M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 35.3B 1.82B Mar/2026
MacroGenics USD 287M 103M Jul/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026